Dex-Moxi-Ketor is a Ophthalmic Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Imprimis Njof, Llc. The primary component is Dexamethasone Sodium Phosphate; Moxifloxacin Hydrochloride Monohydrate; Ketorolac Tromethamine.
| Product ID | 71384-513_638a4320-9c22-4122-e053-2991aa0af758 |
| NDC | 71384-513 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dex-Moxi-Ketor |
| Generic Name | Dexamethasone Phosphate - Moxifloxacin - Ketorolac Tromethamine |
| Dosage Form | Injection, Solution |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2018-01-05 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Imprimis NJOF, LLC |
| Substance Name | DEXAMETHASONE SODIUM PHOSPHATE; MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE; KETOROLAC TROMETHAMINE |
| Active Ingredient Strength | 1 mg/mL; mg/mL; mg/mL |
| Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Quinolone Antimicrobial [EPC],Quinolones [CS],Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Cyclooxygenase Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2018-01-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2018-01-05 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-02-10 |
| Ingredient | Strength |
|---|---|
| DEXAMETHASONE SODIUM PHOSPHATE | 1 mg/mL |
| SPL SET ID: | 62fff769-95d6-0908-e053-2a91aa0a732d |
| Manufacturer | |
| UNII |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DEX-MOXI-KETOR 87351119 5587077 Live/Registered |
HARROW IP, LLC 2017-02-27 |